Reducing the GI Risks of Antiplatelet Therapy and NSAID Use

Updated:Mar 15,2011

Reducing the GI Risks of Antiplatelet Therapy and NSAID Use

  • There is uncertainty about how to best prevent bleeding complications in patients receiving antiplatelet therapy and NSAIDs.
  • Patients are on these agents for longer periods than in the past, increasing their time of risk.
  • Evaluation of the risk profile for each patient is critical.

Supporting Materials
Editorial | Use of Nonsteroidal Antiinflammatory Drugs - An Update for Clinicians | Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents |Cardiology Patient Page: Can Patients With Cardiovascular Disease Take Nonsteroidal Antiinflammatory Drugs?


Network with over 31,000 Heart and Stroke Professionals

  • Connect with others around the world
  • Share and discuss articles by prominent heart and stroke researchers
     
    Join the AHA's Professional Online Network at networking.americanheart.org    Login to AHA's Professional Online Network at networking.americanheart.org